{"slug":"selank-trigeminal","verification":{"valid":true,"entries":1,"head":"9f4b327b7adb0247a5daf2392661b7cf00e94005b8780e8b4a62b80f12953ffb"},"count":1,"models":["grok/grok-4.3"],"yield":{"passes":1,"energy_spent_rows":0,"total_cost_usd":0.022634,"waste_cost_usd":0,"total_tokens":15933,"material_outputs":0,"usd_per_output":null,"models":[{"model":"grok/grok-4.3","passes":1,"cost_usd":0.022634,"tokens_total":15933,"outputs":0,"waste_passes":0,"usd_per_output":null}],"constraints":{"constitution":"/api/articles/constitution","collaborate_schema":"POST /api/protocol/collaborate","pricing_ppm":{"grok-4.3":[1.25,2.5],"grok/grok-4.3":[1.25,2.5],"grok-build-0.1":[1,2],"kimi/moonshot-v1-8k":[0.15,0.15],"gemini/gemini-2.5-flash":[0.075,0.3],"gemini/gemini-2.0-flash-lite":[0.075,0.3],"openai/gpt-4o":[2.5,10],"openai/gpt-4o-mini":[0.15,0.6],"system/reflex":[0,0],"ingest:deterministic":[0,0],"fill-slots":[0,0]}}},"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T00:33:01.967Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"Selank Evidence for Trigeminal Neuralgia: Anxiety and Neurochemistry Layer","register":"source_ledger","body":"## What's breaking down\n\nTrigeminal neuralgia involves sharp, electric-shock-like facial pain along the trigeminal nerve branches. The condition often features nerve irritation or compression that triggers repeated pain signals. Chronic pain episodes frequently layer on top of heightened stress responses and anxiety, which can amplify pain perception and reduce sleep quality. If anxiety chemistry stays elevated, the nervous system may stay in a heightened state that makes recovery slower. Repair pathways for nerve health and emotional regulation can lag behind ongoing degeneration from repeated pain signaling.\n\n## Why Selank might help you\n\n1. **What keeps failing:** Chronic stress chemistry, non-restorative arousal, and anxiety that often accompanies trigeminal pain flares.\n2. **What Selank is studied to do:** Studied for anxiolytic pathways that modulate GABA-related systems without the sedation typical of benzodiazepines.\n3. **Therefore for you:** If the anxiety and neurochemistry layer contributes to your pain experience, Selank is discussed because it targets that repair angle rather than simply suppressing symptoms.\n\n## How these fit together\n\nSingle-compound focus. Selank addresses the anxiety / neurochemistry layer. If your profile includes other peptides, they would target separate degeneration layers such as direct nerve repair or inflammation.\n\n## What the evidence actually shows\n\nHuman trials (preclinical separation): Small Russian studies examined Selank in generalized anxiety disorder. One trial with 62 patients compared Selank to medazepam and reported comparable anxiolytic effects on Hamilton and Zung scales with fewer side effects like sedation (human tier). Another study of 70 patients found Selank plus benzodiazepine improved outcomes and reduced some side effects (human tier). A 2008 trial noted cognitive enhancement alongside anxiety reduction (human tier). No human trials exist for trigeminal neuralgia or trigeminal pain (human tier absent).\n\nRat studies: Selank reduced anxiety-like behaviors in stress models and showed effects on learning in animals with initially poor performance (preclinical tier). One study noted modulation of gene expression related to GABA receptors (preclinical tier). These do not directly address trigeminal nerve conditions.\n\nAnecdotal separation: No specific Reddit threads link Selank to trigeminal neuralgia outcomes. General peptide discussions mention anxiety relief but remain unverified anecdotes.\n\n## What scientists say\n\nRussian researchers describe Selank as producing anxiolytic and nootropic effects in anxiety-asthenic disorders, with mechanisms tied to GABA-A receptor influence and cytokine modulation (mechanistic tier from published abstracts). Western sources note limited large-scale RCTs outside Russia and call for more independent verification (speculative tier on broader adoption).\n\n## What people say on Reddit\n\nTrigeminal neuralgia communities discuss conventional anticonvulsants and surgery but contain no documented Selank experiences in searched threads. Users focus on pain descriptions and standard treatments (anecdotal tier, absent for this peptide).\n\n## What people say on X\n\nSearches yield no posts connecting Selank specifically to trigeminal issues. Broader peptide conversations reference anxiety benefits anecdotally (anecdotal tier).\n\n## What we do not know\n\nDirect effects on trigeminal nerve compression, oxidative stress in the nerve, or pain signal modulation remain unstudied. Long-term human data beyond small Russian cohorts is unavailable. Interactions with common trigeminal medications lack clinical reports.\n\n## Safety and limits\n\nReported human studies note absence of typical benzodiazepine side effects such as sedation, tolerance, or withdrawal. No large Western safety databases exist. All evidence remains preliminary outside approved regions.","claims":[{"id":"c1","text":"Small Russian human trials showed Selank produced anxiolytic effects comparable to medazepam in GAD patients with fewer side effects.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes human data tier for anxiety layer separate from trigeminal-specific claims.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:33:01.564Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No human trials exist examining Selank for trigeminal neuralgia or facial pain.","section":"What the evidence actually shows","tier":"human","source_ids":[],"source_status":"unsourced","why_material":"Clarifies absence of direct condition evidence.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:33:01.564Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Rat studies demonstrated Selank effects on anxiety-like behaviors and GABA receptor gene expression.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Separates animal data from human.","evidence_basis":"derived_inference","weight":0.5,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T00:33:01.564Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/18454096/","title":"Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia","quote":"The effect of selank (30 patients) was compared to that of medazepam (32 patients).","link_status":"timeout","quote_status":"unverified"},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5322660/","title":"Peptide Selank Enhances the Effect of Diazepam in Reducing the Anxiety Level","quote":"The individual administration of Selank was the most effective in reducing elevated levels of anxiety, induced by the administration of a course of test stress in rats.","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":13759,"tokens_out":2174,"cost":0.02263375,"prev_hash":"genesis","hash":"9f4b327b7adb0247a5daf2392661b7cf00e94005b8780e8b4a62b80f12953ffb"}]}